⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
EPRI Launches Flex MOSAIC to Reduce ‘Time to Power’ for Data Centers
globenewswire.com
GOOGL
NVDA
EXC
DTE
LNT
SO
PCG
EIX
PNW
ETR
PPL
SRE
CMS
NI
AEP
XEL
LUV
HON
SI
LIN
PEG
ECL
FE
WEC
NRG
ED
ES
MDU
NE
UTL
CWEN
BEP
TER
MAS
AMAT
MU
INTC
AMD
CDNS
SNPS
VRTX
GILD
AMGN
BIIB
REGN
AZN
NVS
PFE
MRK
JNJ
ABBV
BMY
LLY
TEVA
BCE
CVE
CP
RY
TD
BNS
CM
CNQ
SU
BHP
RIO
VAL
FCX
AA
STLD
CF
MOS
NTR
ADM
BG
CARR
EMR
GOOG
META
S
VZ
T
TMUS
CCI
AMT
EQIX
DLR
IBM
MSFT
AMZN
CSCO
LRCX
KLAC
ADI
TXN
ON
NXPI
INFY
CTSH
ACN
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
globenewswire.com
LLY
Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building
globenewswire.com
LLY
HCA
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
globenewswire.com
LLY
ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider
globenewswire.com
NVS
LLY
Trim RX GLP-1 Weight Loss Medication Claims Evaluated: Investigating the TrimRX Treatment Options
globenewswire.com
LLY
NVO
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at ECO 2026
prnewswire.com
NVO
LLY
Kalohexis Emerges from Stealth to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to Treat Obesity and Metabolic Diseases
prnewswire.com
NVDA
LLY
Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
businesswire.com
LLY
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
prnewswire.com
LLY